International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) is a true mystery. We don’t normally focus on deep sub-penny plays. But this one deserves to be an exception. By our calculation, after its most recent quarterly financial report, the stock now trades at under 0.5x sales on a trailing basis. If you’re not a wonk on the fundamental valuation side, just trust us: that does not happen for a company that has posted two consecutive quarters of gross profitability. It means something is really off here.
According to the release, “data from the Company’s financial statements for the three months ended September 30, 2019 show sequential revenue growth of 30%. The Company also received a large additional sales input that is now receivable and will be reflected in Q4 data but actually reflects the operational success achieved in quarter ended September 30. With these additional sales included in Q3 results, the quarter actually showed sequential top-line growth of 62% on over $225K in total sales.” Big numbers.
International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) bills itself as an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands worldwide.
Based in Nevada, the Company’s expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISWH intends to nurture emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution.
In addition, ISWH has now established itself as a health and wellness company with a focus on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations. These products will be sold through the Company’s website, as well as through established wholesale and retail distribution channels.
The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.
Find out when $ISWH reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, ISWH just announced record quarterly results and tangible progress toward a major partnership announcement. Among those results one will find 14,847% sales growth over trailing six-month period for its Home Healthcare Segment, which is also absurdly positive.
And yet, here we have a stock that is stagnating in triple-zips with a market cap under a half-million. For crying out loud: the company just posted operating top-line performance that adds up to an annualized $900K in sales, with guidance set for Q4 to blow that away.
“We continue to ride a wave of growth in 2019, with ramping sales, big strategic achievements, and what will clearly go down as our best year on record, with the bulk of the action still in front of us during the final seven weeks of the year,” commented Terry Williams, CEO of ISWH. “Based on our visibility right now into current quarter operations, Q3 – strong as it was – is going to pale in comparison to Q4 because most of our topline growth in CBD and Spirits is going to be reflected in the current quarter. That said, Q3 represents another signpost in the course of the Company’s continuing resurgence, particularly for our Home Healthcare segment, and it’s another strong report card showing gross profitability and a big jump in overall sales.”
At this time, carrying a capital value in the market of $374K, ISWH is pulling in trailing 12-month revenues of $365K. In addition, the company is seeing massive recent top-line growth, with sequential quarterly revenues booming higher by 6497.2%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $ISWH stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $ISWH, either long or short, and we have not been compensated for this article.